These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 32315421)

  • 41. Response to 'What does monitoring platelet counts in COVID-19 teach us?'.
    Yang X; Shang Y
    J Thromb Haemost; 2020 Aug; 18(8):2073. PubMed ID: 32379934
    [No Abstract]   [Full Text] [Related]  

  • 42. Response to: Eosinophil count in coronavirus disease 2019: more doubts than answers.
    Lippi G; Sanchis-Gomar F; Henry BM
    QJM; 2021 Feb; 114(1):70-71. PubMed ID: 32877527
    [No Abstract]   [Full Text] [Related]  

  • 43. Response: Acute Hyperglycemic Crises with Coronavirus Disease-19: Case Reports (Diabetes Metab J 2020;44:349-53).
    Kim NY; Ha E; Moon JS; Lee YH; Choi EY
    Diabetes Metab J; 2020 Jun; 44(3):484-485. PubMed ID: 32613781
    [No Abstract]   [Full Text] [Related]  

  • 44. What do monitoring platelet counts in COVID-19 teach us?
    Thachil J
    J Thromb Haemost; 2020 Aug; 18(8):2071-2072. PubMed ID: 32344467
    [No Abstract]   [Full Text] [Related]  

  • 45. First do no harm-beware the risk of therapeutic plasma exchange in severe COVID-19.
    Stahl K; Bode C; David S
    Crit Care; 2020 Jun; 24(1):363. PubMed ID: 32552832
    [No Abstract]   [Full Text] [Related]  

  • 46. Eosinopenia in COVID-19: What we missed so far?
    Davido B; Partouche B; Jaffal K; de Truchis P; Herr M; Pepin M
    J Microbiol Immunol Infect; 2021 Oct; 54(5):1006-1007. PubMed ID: 33648873
    [No Abstract]   [Full Text] [Related]  

  • 47. EOSINOPENIA: an early, effective and relevant COVID-19 biomarker?
    Roca E; Ventura L; Zattra CM; Lombardi C
    QJM; 2021 Feb; 114(1):68-69. PubMed ID: 32877511
    [No Abstract]   [Full Text] [Related]  

  • 48. Reply to "Protective effects of eosinophils against COVID-19: More than an ACE(2) in the hole?".
    Ferastraoaru D; Hudes G; Jerschow E; Jariwala S; Karagic M; de Vos G; Rosenstreich D; Ramesh M
    J Allergy Clin Immunol Pract; 2021 Jun; 9(6):2540. PubMed ID: 34112483
    [No Abstract]   [Full Text] [Related]  

  • 49. Hematological predictors of novel Coronavirus infection.
    Aktas G
    Rev Assoc Med Bras (1992); 2021; 67Suppl 1(Suppl 1):1-2. PubMed ID: 34259763
    [No Abstract]   [Full Text] [Related]  

  • 50. Original article: Soni M. Evaluation of eosinopenia as a diagnostic and prognostic indicator in COVID-19 infection. Int J Lab Hematol. 2020;00:1-5. https://doi.org/10.1111/ijlh.13425.
    van Duijnhoven HLP; Leuvenink J; Keuren JFW
    Int J Lab Hematol; 2021 Dec; 43(6):e287-e289. PubMed ID: 33973723
    [No Abstract]   [Full Text] [Related]  

  • 51. Original Article: Evaluation of eosinopenia as a diagnostic and prognostic indicator in COVID-19 infection.
    Soni M
    Int J Lab Hematol; 2021 Dec; 43(6):e303. PubMed ID: 33973726
    [No Abstract]   [Full Text] [Related]  

  • 52. Eosinopenia is associated with greater severity in patients with coronavirus disease 2019.
    Zhao L; Zhang YP; Yang X; Liu X
    Allergy; 2021 Feb; 76(2):562-564. PubMed ID: 32544252
    [No Abstract]   [Full Text] [Related]  

  • 53. Eosinopenia is associated with adverse outcomes after COVID-19 infection: A perspective from Japan.
    Ito A; Ishida T; Nakanishi Y; Kobe H; Tokioka F
    Respirology; 2023 Jul; 28(7):677-680. PubMed ID: 37105899
    [No Abstract]   [Full Text] [Related]  

  • 54. The authors respond: Anticipating Covid prognosis from white blood cell count.
    Moradi EV; Rezaee R; Morovatdar N; Ghorani V
    Am J Emerg Med; 2021 Sep; 47():297-298. PubMed ID: 33966924
    [No Abstract]   [Full Text] [Related]  

  • 55. RE: Lymphocytes and Eosinophils Associated with the Coronavirus Disease-2019 Severity.
    Duman D; Karakurt Z; Durmuş Koçak N; Adıgüzel N; Yıldız T; Güngör G; Takır HB; Tepetam FM; Günen H; Interest Group OBOTC
    Thorac Res Pract; 2023 Jul; 24(4):236. PubMed ID: 37485716
    [No Abstract]   [Full Text] [Related]  

  • 56. Lymphocytes and Eosinophils Associated with the Coronavirus Disease-2019 Severity.
    Kleebayoon A; Wiwanitkit V
    Thorac Res Pract; 2023 Jul; 24(4):235. PubMed ID: 37485715
    [No Abstract]   [Full Text] [Related]  

  • 57. Platelet count in patients with severe coronavirus disease 2019.
    Kawada T
    EXCLI J; 2021; 20():17-18. PubMed ID: 33510589
    [No Abstract]   [Full Text] [Related]  

  • 58. Eosinophil count in severe coronavirus disease 2019.
    Lippi G; Henry BM
    QJM; 2020 Jul; 113(7):511-512. PubMed ID: 32315429
    [No Abstract]   [Full Text] [Related]  

  • 59. Predictive Value of Eosinophil Count on COVID-19 Disease Progression and Outcomes, a Retrospective Study of Leishenshan Hospital in Wuhan, China.
    Xuan W; Jiang X; Huang L; Pan S; Chen C; Zhang X; Zhu H; Zhang S; Yu W; Peng Z; Su D
    J Intensive Care Med; 2022 Mar; 37(3):359-365. PubMed ID: 34550036
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ultra- and micro-structural changes of respiratory tracts in SARS-CoV-2 infected Syrian hamsters.
    Yang MS; Oh BK; Yang D; Oh EY; Kim Y; Kang KW; Lim CW; Koh GY; Lee SM; Kim B
    Vet Res; 2021 Sep; 52(1):121. PubMed ID: 34530902
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.